Celltrion | 068270 - 贸易债权人

金融业

KRW

KRW 759.44B

现金及等价物

KRW 49.87B

KRW 107.42B

KRW 470.6B

KRW 283.62B

KRW 161.31B

股息收益率

0.41

KRW 12.08B

KRW 17.79B

1.07K

EPS每股收益

KRW 1.58K

股本和储备

KRW 435.96B

KRW 46.98B

债务利息支出

KRW 19B

KRW 621.35M

KRW 412.27B

KRW 36598.01B

KRW 8.88B

KRW 140.68B

KRW 13.72B

普通股股本

KRW 218.61M

67.83

KRW 10.5B

KRW 1150B

销售和管理费用

KRW 12.71B

KRW 122.94B

贸易债权人

KRW 78.68B

应收帐款人

KRW 2049.53B

	贸易债权人	更改		日
Akebia Therapeutics	USD 8.39M		12.8M	2026-03
Alaunos Therapeutics	USD 400K		213K	2026-03
Avita Medical	AUD 8.96M		1.69M	2025-12
Celltrion	KRW 78.68B		25.51B	2025-12
Dianthus Therapeutics	USD 5.27M		4.45M	2026-03
Ionis Pharmaceuticals	USD 26.03M		2.05M	2026-03
IQVIA Holdings	USD 3.64B		112M	2026-03
Moderna	USD 161M		156M	2026-03
Organon & Co	USD 983M		31M	2026-03
Revvity	USD 169.68M		15.78M	2026-03
Tectonic Therapeutic	USD 2.55M		1.46M	2026-03
Viatris	USD 1.2B		93.9M	2026-03
Xeris Pharmaceuticals	USD 11.47M		8.39M	2026-03